The EC inhibits transcription PRR9 and TOC1 at night, which are in turn involved in suppressing CCA1 and LHY levels, which increase during the night.
The EC inhibits transcription PRR9 and TOC1 at night. These, along with the remaining PRR proteins PRR7 and PRR5 are involved in suppressing CCA1 and LHY levels, which increase during the night.